FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/05/067727 [Registered on: 21/05/2024] Trial Registered Prospectively
Last Modified On: 25/04/2024
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   Role of trace elements and Cholesterol in Diabetes Mellitus Patients 
Scientific Title of Study   Analysing the role of serum Magnesium, Zinc, Copper, Iron and Total Cholesterol in type-2 Diabetes Mellitus patients in AVBR Hospital , Wardha. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Mithila Vinayak Sarware 
Designation  Post Graduate Medical Laboratory Technology 
Affiliation  Datta Meghe Institute of Higher Education and Research 
Address  Department of Biochemistry, Datta Meghe Institute of Higher Education and Research , AVBR Hospital, Sawangi Meghe, Wardha.

Wardha
MAHARASHTRA
442001
India 
Phone  7499456009  
Fax    
Email  mithilav.sarware@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Anjali Vagga Manglaram 
Designation  Associate Proffesor, Department of Biochemistry.emistry 
Affiliation  Datta Meghe Institute of Higher Education and Research 
Address  Department of Biochemistry, Jawaharlal Nehru Medical College, Sawangi Meghe, Wardha.

Wardha
MAHARASHTRA
442001
India 
Phone  9970001431  
Fax    
Email  anjali.biochemistry@dmiher.edu.in  
 
Details of Contact Person
Public Query
 
Name  Mithila Vinayak Sarware 
Designation  Post Graduate Medical Laboratory Technology 
Affiliation  Datta Meghe Institute of Higher Education and Research 
Address  Department of Pathology, Datta Meghe Institute of Higher Education and Research , AVBR Hospital, Sawangi Meghe, Wardha.

Wardha
MAHARASHTRA
442001
India 
Phone  7499456009  
Fax    
Email  mithilav.sarware@gmail.com  
 
Source of Monetary or Material Support  
Datta Meghe Institute Of Higher Education and Research, Sawangi Meghe, Wardha-442001, India.  
 
Primary Sponsor  
Name  Datta Meghe Institute Of Higher Education and Research 
Address  Sawangi Meghe, Wardh India 442001 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Mithila Vinayak Sarware  Datta Meghe Institute of Higher Education and Research  Department of Biochemistry, Datta Meghe Institute of Higher Education and Research, Jawaharlal Nehru Medical College, Sawangi Meghe, Wardha.
Wardha
MAHARASHTRA 
7499456009

mithilav.sarware@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committe Datta Meghe Institute of Higher Education and Research, Wardha-442001  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: E119||Type 2 diabetes mellitus without complications,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  NIL  NA 
Comparator Agent  NIL  NA 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  79.00 Year(s)
Gender  Both 
Details  All patients aged 20-79 years having a history of diabetes for more than 3 years at the time of data collection were included. 
 
ExclusionCriteria 
Details  Patients who were pregnant or lactating, taking any electrolyte-altering drugs, taking nutritional supplements such as magnesium-containing laxatives, suffering from chronic disorders of the liver, kidney, and cardiovascular system, endocrine disorders, established psychiatric disorder and on antidepressant and/or antipsychotic therapy, HIV/AIDS, malignancy, and substance abuse were excluded from the study.  
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Correlation of plasma glucose, serum magnesium, copper, zinc, iron, cholesterol will be established in Type 2 diabetes mellitus patients  Assessments will be done at the end of 18 months. 
 
Secondary Outcome  
Outcome  TimePoints 
NIL  NA 
 
Target Sample Size   Total Sample Size="135"
Sample Size from India="135" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   22/07/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

 Individuals diagnosed with Type 2 Diabetes Mellitus (T2DM) are more likely to have obesity, insulin resistance, and a higher incidence of cardiovascular problems in later life. Insulin production, secretion, release, and mode of action can all be impacted by trace metal elements . Diabetes mellitus 2 is linked to changes in the metabolism of trace metals such as magnesium and copper . Since trace metal elements are found in many proteins’ prosthetic groups and function as cofactors in several enzymes, they are naturally occurring inorganic elements that have been suggested as potential treatments for metabolic disorders. This study aims to analyse the role of serum magnesium, zinc, copper, iron and total cholesterol in Type 2 Diabetes Mellitus Patients.

 

 
Close